Non-Permissive Parvovirus B19 Infection: A Reservoir and Questionable Safety Concern in Mesenchymal Stem Cells.
Gloria BuaPasquale MarrazzoElisabetta ManaresiChiara GamberiniLaura BonsiFrancesco AlvianoGiorgio GallinellaPublished in: International journal of molecular sciences (2023)
Mesenchymal stromal/stem cells (MSCs) are multipotent cells with differentiation, immunoregulatory and regenerative properties. Because of these features, they represent an attractive tool for regenerative medicine and cell-based therapy. However, MSCs may act as a reservoir of persistent viruses increasing the risk of failure of MSCs-based therapies and of viral transmission, especially in immunocompromised patients. Parvovirus B19V (B19V) is a common human pathogen that infects bone marrow erythroid progenitor cells, leading to transient or persistent anemia. Characteristics of B19V include the ability to cross the placenta, infecting the fetus, and to persist in several tissues. We thus isolated MSCs from bone marrow (BM-MSCs) and fetal membrane (FM-MSCs) to investigate their permissiveness to B19V infection. The results suggest that both BM- and FM- MSCs can be infected by B19V and, while not able to support viral replication, allow persistence over time in the infected cultures. Future studies are needed to understand the potential role of MSCs in B19V transmission and the conditions that can favor a potential reactivation of the virus.
Keyphrases
- mesenchymal stem cells
- bone marrow
- umbilical cord
- cell therapy
- stem cells
- sars cov
- end stage renal disease
- chronic kidney disease
- single cell
- gene expression
- extracorporeal membrane oxygenation
- induced apoptosis
- risk assessment
- blood brain barrier
- ejection fraction
- current status
- signaling pathway
- intensive care unit
- mechanical ventilation
- cerebral ischemia
- replacement therapy